3451
|
Li X, Chang J, Liu W, Quan E, Balter P, Zhang X. TH-E-BRB-01: Significant Improvement of Plan Quality, Delivery Efficiency and Plan Consistency by VMAT Combined with Automated Inverse Planning Algorithm for Stereotactic Body Radiation Therapy in Centrally/superiorly Located Stage I Non-Small-Cell Lung C. Med Phys 2011. [DOI: 10.1118/1.3613558] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
3452
|
Zhang X, Yan Y, Sharma S, Corry P, Ratanatharathorn V, Moros E. SU-E-T-537: A Dosimetric Study of Gafchromic EBT2 Film for Small Field Size Stereotactic Radiosurgery QA. Med Phys 2011. [DOI: 10.1118/1.3612499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
3453
|
Wang X, Zhang X, Amos R, Salehpour M, Zhang S, Sun T, Strom E, Buchholz T, Hoffman K, Woodward W. SU-E-T-776: External Beam Accelerated Partial Breast Irradiation Using Intensity Modulated Proton Therapy (IMPT). Med Phys 2011. [DOI: 10.1118/1.3612740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
3454
|
Yan Y, Penagaricano J, Corry P, Moros E, Gardner K, Han EY, Zhang X, Chao M, Griffin RJ, Ratanatharathorn V. SU-C-BRB-01: Spatially Fractionated Radiation Therapy (GRID) Using a TomoTherapy Unit. Med Phys 2011. [DOI: 10.1118/1.3611467] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
3455
|
Cai W, Liu X, Dai L, Zhang X, Xu C. Experimental Investigation of Gas Holdup and Slug Lengths in an Upflow Monolith Reactor. Chem Eng Technol 2011. [DOI: 10.1002/ceat.201000464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
3456
|
Quan E, Chang J, Liao Z, Xia T, Liu H, Li X, Balter P, Zhang X. SU-E-T-784: Automated VMAT Treatment Planning for Stage III Lung Cancer: How Does It Compare with IMRT? Med Phys 2011. [DOI: 10.1118/1.3612748] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
3457
|
Zhang X, Xing L. SU-E-I-31: CT Metal Artifact Reduction by Constrained Optimization with a Model-Based Scanning Scheme. Med Phys 2011. [DOI: 10.1118/1.3611604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
3458
|
Liu W, Zhang X, Li Y, Chen W, Mohan R. SU-E-T-845: Benefits from Achillesˈ Heel of Intensity-Modulated Proton Therapy via Worst-Case Robust Optimization. Med Phys 2011. [DOI: 10.1118/1.3612809] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
3459
|
Tian X, Zhang X, Zeng S, Xu Y, Yao Y, Chen Y, Huang L, Zhao Y, Zhang S. Process Analysis and Multi-Objective Optimization of Ionic Liquid-Containing Acetonitrile Process to Produce 1,3-Butadiene. Chem Eng Technol 2011. [DOI: 10.1002/ceat.201000426] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
3460
|
Pattekari P, Zheng Z, Zhang X, Levchenko T, Torchilin V, Lvov Y. Top-down and bottom-up approaches in production of aqueous nanocolloids of low solubility drug paclitaxel. Phys Chem Chem Phys 2011; 13:9014-9. [PMID: 21442095 PMCID: PMC4378541 DOI: 10.1039/c0cp02549f] [Citation(s) in RCA: 92] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Nano-encapsulation of a poorly soluble anticancer drug was demonstrated with a sonication assisted layer-by-layer polyelectrolyte coating (SLbL). We changed the strategy of LbL-encapsulation from making microcapsules with many layers in the walls for encasing highly soluble materials to using a very thin polycation/polyanion coating on low solubility nanoparticles to provide them with good colloidal stability. SLbL encapsulation of paclitaxel resulted in stable 100-200 nm diameter colloids with a high electrical surface ξ-potential (of -45 mV) and drug content in the nanoparticles of 90 wt%. In the top-down approach, nanocolloids were prepared by rupturing a powder of paclitaxel using ultrasonication and simultaneous sequential adsorption of oppositely charged biocompatible polyelectrolytes. In the bottom-up approach paclitaxel was dissolved in organic solvent (ethanol or acetone), and drug nucleation was initiated by the addition of aqueous polyelectrolyte assisted by ultrasonication. Paclitaxel release rates from such nanocapsules were controlled by assembling multilayer shells with variable thicknesses and were in the range of 10-20 h.
Collapse
|
3461
|
Jia L, Lou Y, Tian A, Zhu S, Zhang X. Randomized, multicenter, phase II trial of compound Chinese herbal extract LC09 versus placebo for external treatment of hand-foot syndrome induced by anticancer therapy. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.9049] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3462
|
Shen P, Huang S, He M, Yu L, Shi G, Deng J, Chen J, Yang L, Wang X, Xu N, Zhang X. Reduction of myeloid-derived suppressor cells in peripheral blood by local hyperthermia in patients with advanced solid tumors. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3463
|
Zhang X, Yin L, Yang X, Yang J, Zhou Q, Xu J, Xie Z, An S, Chen S, Wang R, Zhu G, Gu Y, Zhang X, Wu YL. Detection of EGFR mutations with mutation-specific antibodies in primary lesions of non-small cell lung cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.7035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3464
|
Yang J, Zhang X, Su J, Chen H, Tian H, Huang Y, Xu C, Wu YL. Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10517] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3465
|
Messersmith WA, LoRusso P, Cleary JM, Dasari A, Zhang X, Shaik MN, Courtney RD, Randolph S, Shapiro G. A phase I dose-escalation study of the novel gamma secretase inhibitor PF-03084014 in patients (pts) with advanced solid tumors. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.3100] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3466
|
Zhang Y, Zhang X, Wu YL, Zhang G, Cheng H, Dong S. Expression of Adam28 as a prognostic biomarker of survival in patients with early-stage non-small cell lung cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3467
|
Zhang X, Ren L, Gong Y, Huang M, Zhou L, Zhu J, Ding Z, Hou M, Lu Y. Monitoring of the estimated glomerular filtration rate (eGFR) in patients with small cell lung cancer during chemotherapy: Equations based on serum creatinine or cystatin C? J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e19741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3468
|
Wang Y, Zhang X, Wu YL. Homozygous deletion of ADAM3A revealed by genome-wide analysis of early-stage NSCLC in China showed to be correlated with poor prognosis. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21177] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3469
|
Feng L, Jun H, CAI B, LU N, DU L, MA L, Xu S, Zhang X, Xie C. Clinical observation in nasopharyngeal carcinoma (NPC) treated with the anti-EGFR monoclonal antibody followed by helical tomotherapy. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e16010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3470
|
Nie Q, An S, Yang X, Zhong W, Liao R, Yang J, Zhang X, Chen Z, Su J, Xie Z, Huang Y, Wu YL. CYP1A1*2A polymorphism as a prognostic factor for the advanced lung cancer patients treated with EGFR-TKI and its correlation with EGFR mutation. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e13098] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3471
|
Zhong W, Yang X, Liao R, Nie Q, Dong S, Su J, Zhang X, Zhou Q, Yang J, Wu YL. Induction erlotinib or gemcitabine/carboplatin factorial assignment therapy in stage IIIA-N2 non-small cell lung cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e17512] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3472
|
Chen L, Chen H, Zhang X, Liang B, Zhang G, MA G, Zheng J. Evaluation of the adverse event of nimotuzumab combined therapy in patients with advanced carcinoma. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e13081] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3473
|
Gong J, Zhang X, Shen L, Li J, Li Y, Li J, Zhang X, Zhou J, Dong K. Paclitaxel and cisplatin in patients with advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e14568] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3474
|
Huang M, Luo D, Zhang X, Yu M, Zou B, Li Y, Long J, Wang J, Peng F, Xu Y, Li L, Ren L, Hou M, Lu Y. The effect of erlotinib after gefitinib failure in advanced non-small cell lung cancer (NSCLC) patients with poor performance status (PS): A matched-pair case-control study. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e18057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3475
|
Jiang J, Wu C, Zheng X, Zhou Q, Zhang X, Xu X, Lu B, Ju J. Prognostic values of microRNAs in phase III clinical trial gastric cancer patients treated with S-1/oxaliplatin or doxifluridine/oxaliplatin. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.4073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|